Vega UGA

Language: Spanish
References: 10
Page: 377-384
PDF size: 203.92 Kb.

ABSTRACT

The cervical cáncer is one of the most frecuently in women, being the Human Papillomavirus the most importante risk , and they high risk subtypes 6,11,16 and 18 for the development in the transformation zone, being the Cervical Intraepithelial Neoplasm precursors. Through the smears and the news vaccines against Human Papillomaviruses prevention is performed, its management depends on the result, being the colposcopy the basis for managing the most of the lesion found it.

REFERENCES

1. Díaz María. Hu,an Papilloma Virus- Prevention and treatment. Obstet Gynecol Clin N Am 2008, 35: 199-217.

2. Echelman D., et al. Management of Cervical Precancers: A Global Perspective. Hematol Oncol Clin N Am 2012, 26: 31-44.

3. Lea J., et al. Cervican Cancer.Obstet Gynecol Clin N Am 2012, 39: 233-253.

4. Mosciki A. Management of Adolescents Who Have Abnormal cytology and Histology. Obstet Gynecol Clin N Am 2008, 35: 633-643

5. Park K. Neoplastic Lesions Of The Cervix. Surgical Pathology 2011, 4: 11- 86.

6. Safaeian M. ,et al. Cervical Cancer Prevention-Cervical Screening: Science in Evolution. Obstet Gynecol Clin N Am 2007, 34: 739-760

7. Warren J., et al. Cervical Cancer Screening and Updated Pap Guidelines. Prime Care Clin Office Pract 2009, 36: 131-149

8. . Waxman A., et al. Preventing Cervical Cancer: The Pap Test and the HPV Vaccine. Med Clin N Am 2008, 92:1059-1082

9. Weinstein L., et al. Screening and Prevention: Cervical Cancer. Prim Care Clin Office 2009, 36: 559-574.

10. Wright TC,et al. 2006 Consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol 2007;197:346–55